secwatch.observer — SEC 8-K summary
======================================

Issuer:     NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)
CIK:        0000787253
Form:       8-K
Filed at:   2021-09-21T23:59:59+00:00
Accession:  0001437749-21-022445
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NAI reports record FY2021 sales $178.5M, net income $10.8M; guides FY2022 sales up 5-10%
--------------------------------------------------------------------------------

- Q4 net sales $44.4M (+26.5% YoY); diluted EPS $0.47 vs $0.27 prior year.
- FY2021 net sales $178.5M (+50.2%); net income $10.8M vs net loss $1.6M in FY2020.
- CarnoSyn royalty revenue up 102.6% in Q4; private-label manufacturing sales +54.6% for year.
- FY2022 guidance: net sales +5-10% YoY; operating income 7-9% of sales; first half slower due to supply chain.
- Appoints Dr. Guru Ramanathan (former GNC Chief Innovation Officer) as independent director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/787253/000143774921022445/0001437749-21-022445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/787253/000143774921022445/naii20210920_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-022445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer